My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
Discover the secret world of unlisted shares — analyse India's top pre-IPO companies and invest before they hit the markets
Pharma major Lupin shares halved losses in afternoon trade Thursday on approval from the US health regulator for for anti-alzheimer drug. The stock reduced its losses to 2 percent from 4 percent intraday.
You are already a Moneycontrol Pro user.